Evaluation of a tool to benchmark hospital antibiotic prescribing in the United Kingdom

Pharmacy World and Science

Volumn 30, Issue 1, 2008, Pages 73-78

  Fitzpatrick, Raymond W ^a   Edwards, Catherine M C ^b  

^a ROYAL WOLVERHAMPTON HOSPITALS NHS TRUST   (United Kingdom)

^b Pharmacy Department   (United Kingdom)

Author keywords

Analysis; Antibiotics; Benchmarking; Defined Daily Doses; Drug usage; Hospital; Prescribing; United Kingdom

Indexed keywords

ANTIBIOTIC AGENT; CEFUROXIME; CIPROFLOXACIN; CLARITHROMYCIN; ERYTHROMYCIN; ISONIAZID; QUINOLONE; RIFAMPICIN;

ARTICLE; CLINICAL ASSESSMENT TOOL; CLINICAL PRACTICE; DEFINED DAILY USE; DOSE CALCULATION; DRUG FORMULATION; DRUG USE; FINISHED CONSULTANT EPISODE; HOSPITAL; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PRESCRIPTION; SENSITIVITY ANALYSIS; UNITED KINGDOM;

ANTI-BACTERIAL AGENTS; BENCHMARKING; CEFUROXIME; CIPROFLOXACIN; COHORT STUDIES; DATA COLLECTION; DRUG UTILIZATION; GREAT BRITAIN; HOSPITALS; HUMANS; ISONIAZID; MEDICATION SYSTEMS, HOSPITAL; PHARMACY SERVICE, HOSPITAL; PHYSICIAN'S PRACTICE PATTERNS; PILOT PROJECTS; PRACTICE GUIDELINES AS TOPIC; PRESCRIPTIONS, DRUG; RIFAMPIN;

EID: 36448948264     PISSN: 09281231     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11096-007-9147-6     Document Type: Article

References (14)

1. Department of Health, Prescriptions Dispensed in the Community, Statistics for 1993-2003: England, Statistics Bulletin, London, Department of Health, 2004, ISBN 1 841882 8661.
2. Audit Commission. A spoonful of sugar: medicines management in NHS hospitals. London: Audit Commission; (2001). ISBN 1 86240 321X.
3. World Health Organisation Collaborating Centre for Drug Statistics Methodology. Complete ATC index with DDD's. Oslo, Norwegian: Institute of Public Health; 2005.
4. Pelle B, Gilchrist M, Lawson W, Jacklin A, Dean Franklin B. Using defined Daily Doses to study the use of antibacterials in U.K. hospitals. Hosp Pharm 2006;13:133-6.
5. Department of Health. HES Factsheet Glossary of Terms. London: Department of health; 2004.
6. Curtis C, Fitzpatrick RW, Marriott J. An evaluation of quinolone prescribing in a group of acute hospitals: development of an objective measure of usage. Pharm World Sci 2002;24(2):61-6.
7. Curtis C, Langley CA, Marriott JF, Wilson KA. A comparison of antibiotic prescribing indicators and medicines management scoring in secondary care. I J P P 2003;11:R54.
8. Department of Health. The Governments Response to the House of Lords Select Committee on Science and Technology Report 'Resistance to Antibiotics and other Antimicrobial Agents. London:HMSO; 1998, ISBN 0104789980.
9. Department of Health. U.K. antimicrobial resistance strategy and action plan. London: Department of Health; 2000.
10. Rosdahl VK, and Pederson KB. The Copenhagen Recommendations. European Union Conference, The Microbial Threat. 1998 1-52. Ministry of health, and Ministry of food, agriculture, and Fisheries, Copenahgen Denmark.
11. Jolley AE, Davies AJ, McLeod DT. Audit of the use of erythromycin in the treatment of community acquired lower respiratory infections. Respir Med 1992;86:503-5.
12. Binley's Directory of NHS Management. Volume 11 No. 3. Beechwood House Publishing Ltd. 2003/4 ISSN 0967-7917.
13. Government Statistical Services. Hospital Episode Statistics. England: Financial year 2002-3. Department of Health. Available at http://www.dh.gov.uk/ PublicationsAndStatistics/Statistics/HospitalEpisodeStatistics/HESFreeData.
14. Curtis C, Marriot J, Langley C. Development of a prescribing indicator for objective quantification of antibiotic use in secondary care. J Antimicrob Chemother 2004;54:529-33.